This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Feb 20;30(6):575-6.

doi: 10.1200/JCO.2011.36.6385. Epub 2012 Jan 30.

Testing for discordance at metastatic relapse: does it matter?

PMID: 22291087
DOI: 10.1200/JCO.2011.36.6385

Editorial

Testing for discordance at metastatic relapse: does it matter?

Stephen Chia. J Clin Oncol. 2012.

. 2012 Feb 20;30(6):575-6.

doi: 10.1200/JCO.2011.36.6385. Epub 2012 Jan 30.

Author

PMID: 22291087
DOI: 10.1200/JCO.2011.36.6385

No abstract available

PubMed Disclaimer

Comment in

Testing for discordance at metastatic relapse of breast cancer matters.
van Diest PJ, Hoefnagel LD, van der Wall E. van Diest PJ, et al. J Clin Oncol. 2012 Aug 20;30(24):3031; author reply 3031-2, 3032-3. doi: 10.1200/JCO.2012.42.6734. Epub 2012 Jul 16. J Clin Oncol. 2012. PMID: 22802319 No abstract available.

Comment on

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.
Amir E, Miller N, Geddie W, Freedman O, Kassam F, Simmons C, Oldfield M, Dranitsaris G, Tomlinson G, Laupacis A, Tannock IF, Clemons M. Amir E, et al. J Clin Oncol. 2012 Feb 20;30(6):587-92. doi: 10.1200/JCO.2010.33.5232. Epub 2011 Nov 28. J Clin Oncol. 2012. PMID: 22124102 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information